Decreased expression and aberrant methylation of raf kinase inhibitory protein gene in esophageal squamous cell carcinoma

Cancer Investigation

Volumn 30, Issue 10, 2012, Pages 703-711

  Guo, Wei ^a   Dong, Zhiming ^b   Lin, Xinwen ^b   Zhang, Minghui ^b   Kuang, Gang ^b   Zhu, Tienian ^a  

^a BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; Expression; Methylation; RKIP

Indexed keywords

AZACITIDINE; MESSENGER RNA; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ADULT; AGED; ARTICLE; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DYSPLASIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84870691993     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.732164     Document Type: Article

References (30)

1. Shahbaz Sarwar CM, Luketich JD, Landreneau RJ, Abbas G. Esophageal cancer: an update. Int J Surg 2010;8(6): 417-422.
2. Guo W, Zhou RM, Wan LL, Wang N, Li Y, Zhang XJ, Dong XJ. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and C and risk of esophageal squamous cell carcinoma in a population of high incidence region of North China. J Cancer Res Clin Oncol 2008: 134(2): 263-270.
3. Wu DL, Sui FY, Jiang XM, Jiang XH.Methylation in esophageal carcinogenesis.World J Gastroenterol 2006;12(43): 6933-6940.
4. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM, KolchW. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999;401(6749): 173-177.
5. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 2000;351(pt. 2): 289-305.
6. Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 2005;6(11): 827-837.
7. Hagan S, Garcia R, Dhillon A, KolchW. Raf kinase inhibitor protein regulation of raf and MAPK signaling. Methods Enzymol 2006;407: 248-259.
8. Keller ET, Fu Z, Brennan M. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol 2004;68(6): 1049-1053.
9. Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 2003;95(12): 878-889.
10. Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, Roy R, Braastad C, Sun Y, Mukhopadhyay A, Aggarwal BB, Darnowski J, Pantazis P, Wyche J, Fu Z, Kitagwa Y, Keller ET, Sedivy JM, Yeung KC. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 2004;279(17): 17515-17523.
11. Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, Garćia JJ, Kolch W. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 2005;11(20): 7392-7397.
12. Li HZ, Gao Y, Zhao XL, Liu YX, Sun BC, Yang J, Yao Z. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res 2009;7(6): 832-840.
13. Li HZ, Wang Y, Gao Y, Shao J, Zhao XL, Deng WM, Liu YX, Yang J, Yao Z. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 2008;6(6): 917-928.
14. Schuierer MM, Bataille F, Hagan S, Kolch W, Bosserhoff AK. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 2004;64(15): 5186-5192.
15. Park S, Yeung ML, Beach S, Shields JM, YeungKC. RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene 2005;24(21): 3535-3540.
16. Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR, Lugli A. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression andmetastasis in colorectal cancer. Am J Clin Pathol 2007;127(5): 820-827.
17. Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, Garćia JJ, Scott L, Fyfe N, Murray GI, Kolch W. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 2006;24(36): 5672-5679.
18. Lee HC, Tian B, Sedivy JM, Wands JR, Kim M. Loss of raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 2006;131(4): 1208-1217.
19. SchuiererMM, Btaille F,Weiss TS, Hellerbrand C, Bosserhoff AK. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep 2006;16(3): 451-456.
20. Al-Mulla F,Hagan S, Al-AliW, Jacob SP, Behbehani AI, BitarMS, Dallol A, Kolch W. Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol 2008;61(4): 524-529.
21. Nguyen CT,Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G, Jones PA. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-Aza-2'-deoxycytidine. Cancer Res 2002;62(22): 6456-6461.
22. GuoW, Dong Z, Chen Z, Yang Z, WenD, Kuang G, Guo Y, Shan B. Aberrant CpG Island hypermethylation of RASSF1A in gastric cardia adenocarcinoma. Cancer Invest 2009;27(4): 459-465.
23. Bouras T, Southey MC, Venter DJ. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res 2001;61(3): 903-907.
24. Bernier I, Tresca JP, Jolles P. Ligand-binding studies with a 23 kDa protein purified frombovine brain cytosol. Biochim Biophys Acta 1986;871(1): 19-23.
25. Granovsky AE, Rosner MR. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res 2008;18(4): 452-457.
26. Klysik J, Theroux SJ, Sedivy JM, Moffit JS, Boekelheide K. Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal 2008;20(1): 1-9.
27. Zhang L, Fu Z, Binkley C, Giordano T, Burant CF, Logsdon CD, Simeone DM. Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery 2004;136(3): 708-715.
28. Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W, Sedivy JM. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 2001;21(21): 7207-7217.
29. Minoo P, Baker K, Goswami R, Chong G, Foulkes WD, Ruszkiewicz AR, Barker M, Buchanan D, Young J, Jass Jr. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2006;55(10): 1467-1474.
30. Martinho O, Gouveia A, Silva P, Pimenta A, Reis RM, Lopes JM. Loss of RKIP expression is associated with poor survival in GISTs. Virchows Arch 2009;455(3): 277-284.